SKI Market

A+| A| A-|

Indian Indices

Sensex

77,708.52 -442.93
( -0.57%)

Global Indices

Nasdaq

52,169.86 -404.11
(-0.77%)

Dow Jones

7,480.34 -74.43
(-0.99%)

Hang Seng

63,887.74 -2,947.80
(-4.41%)

Nikkei 225

10,542.79 -57.58
(-0.54%)

Forex

USD-INR

96.36 0.10
(0.10%)

EUR-INR

110.37 0.25
(0.23%)

GBP-INR

130.11 0.62
(0.47%)

JPY-INR

0.59 0.00
(0.06%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Onyx Biotec Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

93585

INE0WVU01018

30.5601085

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

ONYX

68.18

EPS(TTM)

Face Value()

Div & Yield %

Back

KDDL consolidated net profit declines 29.20% in the December 2025 quarter

Feb 11,2026

Net profit of KDDL declined 29.20% to Rs 22.99 crore in the quarter ended December 2025 as against Rs 32.47 crore during the previous quarter ended December 2024. Sales rose 26.42% to Rs 596.72 crore in the quarter ended December 2025 as against Rs 472.03 crore during the previous quarter ended December 2024.

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	596.72	472.03	26
OPM %	13.88	16.50	-
PBDT	90.11	80.66	12
PBT	56.82	56.71	0
NP	22.99	32.47	-29

77,708.52 -442.93 ( -0.57%)

52,169.86 -404.11 (-0.77%)

7,480.34 -74.43 (-0.99%)

63,887.74 -2,947.80 (-4.41%)

10,542.79 -57.58 (-0.54%)

96.36 0.10 (0.10%)

110.37 0.25 (0.23%)

130.11 0.62 (0.47%)

0.59 0.00 (0.06%)